Signaturefd LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 14.8% during the first quarter, Holdings Channel reports. The institutional investor owned 7,933 shares of the pharmacy operator’s stock after buying an additional 1,024 shares during the period. Signaturefd LLC’s holdings in CVS Health Corporation were worth $623,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. LSV Asset Management increased its stake in shares of CVS Health Corporation by 44.2% in the first quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after buying an additional 1,404,384 shares in the last quarter. Swiss National Bank raised its position in shares of CVS Health Corporation by 26.9% in the first quarter. Swiss National Bank now owns 3,826,410 shares of the pharmacy operator’s stock valued at $300,373,000 after buying an additional 811,100 shares during the last quarter. Karp Capital Management Corp purchased a new position in shares of CVS Health Corporation during the first quarter valued at $55,824,000. Thornburg Investment Management Inc. raised its position in shares of CVS Health Corporation by 31.8% in the first quarter. Thornburg Investment Management Inc. now owns 2,712,089 shares of the pharmacy operator’s stock valued at $212,899,000 after buying an additional 654,058 shares during the last quarter. Finally, Crawford Investment Counsel Inc. raised its position in shares of CVS Health Corporation by 780.7% in the first quarter. Crawford Investment Counsel Inc. now owns 643,617 shares of the pharmacy operator’s stock valued at $50,524,000 after buying an additional 570,535 shares during the last quarter. 81.92% of the stock is owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.34% during trading on Friday, reaching $79.41. The company’s stock had a trading volume of 2,985,502 shares. The stock’s 50 day moving average price is $78.83 and its 200-day moving average price is $78.96. The firm has a market cap of $80.73 billion, a PE ratio of 15.82 and a beta of 0.91. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $98.44.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.02. The company had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. CVS Health Corporation’s revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 EPS. Equities analysts predict that CVS Health Corporation will post $5.88 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/signaturefd-llc-has-623000-position-in-cvs-health-corporation-cvs/1478262.html.

CVS has been the topic of several research reports. Jefferies Group LLC reaffirmed a “hold” rating and issued a $82.00 target price on shares of CVS Health Corporation in a research report on Friday, June 9th. Vetr raised CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 target price on the stock in a report on Wednesday, May 24th. Evercore ISI reaffirmed an “outperform” rating and issued a $88.00 target price (up previously from $87.00) on shares of CVS Health Corporation in a report on Wednesday, May 3rd. Cowen and Company reaffirmed an “outperform” rating and issued a $86.00 target price on shares of CVS Health Corporation in a report on Tuesday, June 13th. Finally, Tigress Financial initiated coverage on CVS Health Corporation in a research report on Thursday, April 27th. They issued a “buy” rating for the company. Eight research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $91.27.

In related news, CFO David M. Denton sold 230,510 shares of CVS Health Corporation stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $80.00, for a total value of $18,440,800.00. Following the sale, the chief financial officer now owns 176,983 shares of the company’s stock, valued at approximately $14,158,640. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Helena Foulkes sold 20,332 shares of CVS Health Corporation stock in a transaction that occurred on Monday, June 19th. The stock was sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the completion of the sale, the executive vice president now directly owns 59,300 shares in the company, valued at approximately $4,564,914. The disclosure for this sale can be found here. Insiders sold a total of 271,175 shares of company stock worth $21,632,597 in the last ninety days. 0.61% of the stock is currently owned by insiders.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.